Skip to content

The Lipid-Regulating Effects of Electroacupuncture Based on the Gut Microbiota-Host Abnormal Metabolism Relationship and the Integrative Discrimination of Multi-Omics Biomarkers

The Lipid-Regulating Effects of Electroacupuncture Based on the Gut Microbiota-Host Abnormal Metabolism Relationship and the Integrative Discrimination of Multi-Omics Biomarkers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000211
Enrollment
Unknown
Registered
2024-08-11
Start date
2024-08-18
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemia

Interventions

Electroacupuncture Group:Electroacupuncture Intervention
Sham Electroacupuncture Group:Sham Electroacupuncture Intervention

Sponsors

Foshan Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 65 Years

Inclusion criteria

Inclusion criteria: A. Meeting the diagnostic criteria for the dyslipidemia/hypercholesterolemia, and having high low-density lipoprotein cholesterol (LDL-C = 3.4 mmol/L (130 mg/dL)); B. Aged between 55-65 years; C. Those understanding the trial and having signed the informed consent form. *The normal control population included should meet the following inclusion criteria: TC < 5.2mmol/L, TG < 1.7mmol/L, non-HDL-C < 3.4mmol/L, and not meet the above-mentioned diagnostic criteria for hyperlipidemia.

Exclusion criteria

Exclusion criteria: Participants will be excluded if they meet one or more of the following criteria: A. With immune-related diseases; B. With major internal, oncological, or other significant diseases; C. In the acute phase of a cold, acute infection, or other acute illnesses, or with inflammation, scars, or trauma at the operation site, or with severe systemic infections; D. With infectious diseases such as syphilis or AIDS; E. With severe primary diseases of the hematopoietic system or abnormal coagulation function; F. Taking dietary supplements or other known lipid metabolism-affecting medications; G. Those with severe cognitive impairment or unable to cooperate; H. Receiving other treatments that may affect the evaluation of the response to this intervention; I. During breastfeeding or pregnant phase, or planning to become pregnant; J. Having received acupuncture treatment since the past six months.

Design outcomes

Primary

MeasureTime frame
Change of Low-Density Lipoprotein Cholesterol (LDL-C);

Secondary

MeasureTime frame
Change of eating behavior;Reduction in cardiovascular disease risk;Obvious fatigue relief rate;Change of the fatigue degree;Change of gastrointestinal symptom;Dietary nutritional quality;

Countries

China

Contacts

Public ContactPeiming Zhang

Foshan Hospital of Traditional Chinese Medicine

20202110151@stu.gzucm.edu.cn13416472131

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026